These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 16863479)

  • 1. Management of acute decompensated heart failure: treatment, controversy, and future directions.
    Munger MA
    Pharmacotherapy; 2006 Aug; 26(8 Pt 2):131S-138S. PubMed ID: 16863479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Natriuretic peptides in the therapy of acute decompensated heart failure].
    Gassanov N; Caglayan E; Erdmann E; Er F
    Dtsch Med Wochenschr; 2011 Aug; 136(34-35):1738-43. PubMed ID: 21877307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The safety of intravenous diuretics alone versus diuretics plus parenteral vasoactive therapies in hospitalized patients with acutely decompensated heart failure: a propensity score and instrumental variable analysis using the Acutely Decompensated Heart Failure National Registry (ADHERE) database.
    Costanzo MR; Johannes RS; Pine M; Gupta V; Saltzberg M; Hay J; Yancy CW; Fonarow GC
    Am Heart J; 2007 Aug; 154(2):267-77. PubMed ID: 17643575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of nesiritide in patients with acute decompensated heart failure.
    DeWald TA; Hernandez AF
    Expert Rev Cardiovasc Ther; 2010 Feb; 8(2):159-69. PubMed ID: 20136602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controversy and conflict in the treatment of acute decompensated heart failure: nesiritide as evidence-based treatment.
    Munger MA; Ng TM; Van Tassell BW
    Pharmacotherapy; 2007 May; 27(5):619-25. PubMed ID: 17461695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dyspnea as an end point in clinical trials of therapies for acute decompensated heart failure.
    Teerlink JR
    Am Heart J; 2003 Feb; 145(2 Suppl):S26-33. PubMed ID: 12594449
    [No Abstract]   [Full Text] [Related]  

  • 7. Vasodilators in the management of acute heart failure.
    Elkayam U; Janmohamed M; Habib M; Hatamizadeh P
    Crit Care Med; 2008 Jan; 36(1 Suppl):S95-105. PubMed ID: 18158484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The development of new medical treatments for acute decompensated heart failure.
    Teerlink JR
    Heart Fail Monit; 2002; 2(4):129-37. PubMed ID: 12634887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute decompensated heart failure: best evidence and current practice.
    Mehta R; Feldman D
    Minerva Cardioangiol; 2005 Dec; 53(6):537-47. PubMed ID: 16333237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic therapy for acute heart failure.
    Tang WH
    Cardiol Clin; 2007 Nov; 25(4):539-51; vi. PubMed ID: 18063158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemodynamic and clinical effects of ularitide in decompensated heart failure.
    Mitrovic V; Seferovic PM; Simeunovic D; Ristic AD; Miric M; Moiseyev VS; Kobalava Z; Nitsche K; Forssmann WG; Lüss H; Meyer M
    Eur Heart J; 2006 Dec; 27(23):2823-32. PubMed ID: 17074775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral levosimendan in patients with severe chronic heart failure --the PERSIST study.
    Nieminen MS; Cleland JG; Eha J; Belenkov Y; Kivikko M; Põder P; Sarapohja T
    Eur J Heart Fail; 2008 Dec; 10(12):1246-54. PubMed ID: 18945637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of acute decompensated heart failure in an evidence-based era: what is the evidence behind the current standard of care?
    Fares WH
    Heart Lung; 2008; 37(3):173-8. PubMed ID: 18482628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nesiritide: trials and tribulations.
    Arora RR
    J Cardiovasc Pharmacol Ther; 2006 Sep; 11(3):165-9. PubMed ID: 17056828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controversy and conflict in the treatment of acute decompensated heart failure: limited role for nesiritide.
    Noviasky JA
    Pharmacotherapy; 2007 May; 27(5):626-32. PubMed ID: 17461696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Standardizing care for acute decompensated heart failure in a large megatrial: the approach for the Acute Studies of Clinical Effectiveness of Nesiritide in Subjects with Decompensated Heart Failure (ASCEND-HF).
    Ezekowitz JA; Hernandez AF; Starling RC; Yancy CW; Massie B; Hill JA; Krum H; Diaz R; Ponikowski P; Metra M; Howlett JG; Gennevois D; O'Connor CM; Califf RM; Fonarow GC
    Am Heart J; 2009 Feb; 157(2):219-28. PubMed ID: 19185628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lowered B-type natriuretic peptide in response to levosimendan or dobutamine treatment is associated with improved survival in patients with severe acutely decompensated heart failure.
    Cohen-Solal A; Logeart D; Huang B; Cai D; Nieminen MS; Mebazaa A
    J Am Coll Cardiol; 2009 Jun; 53(25):2343-8. PubMed ID: 19539144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute decompensated heart failure: update on new and emerging evidence and directions for future research.
    Givertz MM; Teerlink JR; Albert NM; Westlake Canary CA; Collins SP; Colvin-Adams M; Ezekowitz JA; Fang JC; Hernandez AF; Katz SD; Krishnamani R; Stough WG; Walsh MN; Butler J; Carson PE; Dimarco JP; Hershberger RE; Rogers JG; Spertus JA; Stevenson WG; Sweitzer NK; Tang WH; Starling RC
    J Card Fail; 2013 Jun; 19(6):371-89. PubMed ID: 23743486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute heart failure with dyspnoea: initial treatment. Furosemide and trinitrine, despite the lack of a proven survival benefit.
    Prescrire Int; 2011 Jun; 20(117):156-60. PubMed ID: 21678708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic therapies for acutely decompensated heart failure.
    Fonarow GC
    Rev Cardiovasc Med; 2002; 3 Suppl 4():S18-27. PubMed ID: 12439427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.